icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
Boston MA
November 2019
Back grey_arrow_rt.gif
 
 
 
Safety and Efficacy of Velpatasvir, Sofosbuvir and Voxilaprevir-based Regimens for the Treatment of HCV Genotype 1-6: Results of the HCV-TARGET Study
 
 
  AASLD 2019 Nov 8-12 Boston
Reported by Jules Levin
 
Zeuzem S, Sulkowski MS, Lim JK, Morelli GJ, Khalili M, Ben-Ari Z, Park JS, Reddy RK, Shiffman ML, Dong M, Vainorius M, Fried MW, Nelson DR, Terrault N

1113191

1113192

1113193

1113194

1113195

1113196